Posted at 11 Jan, 17:34h in Press Release by adialpharma 0 Comments 0 Likes Share Adial Pharmaceuticals Receives Notice of Allowance for Third U.S. Patent Covering AD04 for the Treatment for Opioid Use Disorder
Sorry, the comment form is closed at this time.